MarketPeel
Insider Trading Intelligence
KP

Kevin Puylaert

SOPH
CHIEF SALES OFFICER · SOPHIA GENETICS SA · CIK 0002119354
FILING MIX · LIFETIME36%/64%
BUYS
4
SELLS
7
TOTAL VALUE
$3.5K
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
148,164
AVG SELL PX
$4.85
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 28 pending
Forward-return performance of every backtestable P/S trade by Kevin Puylaert, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+100.00%-2.68%+2.07%-4.75%-6.14%
14d6+0.00%+3.40%+5.03%-1.63%-2.71%
30d6+16.67%+1.61%+10.45%-6.78%-9.95%
60d6(4 pending)+50.00%+0.08%+12.51%-14.97%-14.97%
90d6(6 pending)
180d6(6 pending)
1y6(6 pending)
2y6(6 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SOPH · 148,164 shares · as of May 19, 2026
037,21474,427111,641148,854SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 4 buys / 7 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
SOPH
SOPHIA GENETICS SA
SALE
Chief Sales Officer
33$4.54$150148,164May 19, 2026May 20, 2026
SOPH
SOPHIA GENETICS SA
SALE
Chief Sales Officer
33$5.08$168148,197Apr 20, 2026Apr 21, 2026
SOPH
SOPHIA GENETICS SA
SALE
Chief Sales Officer
548$4.86$2.7K148,306Apr 6, 2026Apr 8, 2026
SOPH
SOPHIA GENETICS SA
SALE
Chief Sales Officer
30$4.83$145148,230Apr 6, 2026Apr 8, 2026
SOPH
SOPHIA GENETICS SA
SALE
Chief Sales Officer
46$4.86$224148,260Apr 6, 2026Apr 8, 2026
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
56,46856,468Apr 2, 2026Apr 3, 2026
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
82,33582,335Apr 2, 2026Apr 3, 2026
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
82,33582,335Apr 2, 2026Apr 8, 2026
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
56,468148,854Apr 2, 2026Apr 8, 2026
SOPH
SOPHIA GENETICS SA
SALE
Chief Sales Officer
3$4.71$1492,383Mar 31, 2026Apr 1, 2026
SOPH
SOPHIA GENETICS SA
SALE
Chief Sales Officer
33$4.76$15792,386Mar 19, 2026Mar 20, 2026
Other insiders · SOPH
Loading peer insiders…
About this filer
CIK 0002119354
ROLE
Chief Sales Officer
PRIMARY
SOPH
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002119354DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback